Oncogene-targeting nanoprobes for early imaging detection of tumor

J Nanobiotechnology. 2023 Jun 21;21(1):197. doi: 10.1186/s12951-023-01943-x.

Abstract

Malignant tumors have been one of the major reasons for deaths worldwide. Timely and accurate diagnosis as well as effective intervention of tumors play an essential role in the survival of patients. Genomic instability is the important foundation and feature of cancer, hence, in vivo oncogene imaging based on novel probes provides a valuable tool for the diagnosis of cancer at early-stage. However, the in vivo oncogene imaging is confronted with great challenge, due to the extremely low copies of oncogene in tumor cells. By combining with various novel activatable probes, the molecular imaging technologies provide a feasible approach to visualize oncogene in situ, and realize accurate treatment of tumor. This review aims to declare the design of nanoprobes responded to tumor associated DNA or RNA, and summarize their applications in detection and bioimaging for tumors. The significant challenges and prospective of oncogene-targeting nanoprobes towards tumors diagnosis are revealed as well.

Keywords: Activatable nanoprobe; Message RNA; Molecular imaging; Oncogene.

Publication types

  • Review

MeSH terms

  • Early Detection of Cancer*
  • Humans
  • Neoplasms* / diagnostic imaging
  • Oncogenes
  • Optical Imaging / methods